PHT Corporation Promotes Dwight Cooper to Vice President of Client Services

PHT Corporation Promotes Dwight Cooper to Vice President of Client Services

Global ePRO market leader appoints highly respected 15 year pharmaceutical industry veteran to key role as it maintains strong 2009 growth

BOSTON--(BUSINESS WIRE)--PHT Corporation, the leading provider of ePRO solutions used in pharmaceutical and biotechnology clinical trials worldwide, today announced the promotion of company executive Dwight Cooper to Vice President of Client Services.

Mr. Cooper has over 15 years of experience providing leadership to software teams developing applications for the pharmaceutical industry, and 20 years of experience designing and developing commercial software applications. Previously he was Global Director of Technical Services at PHT, with responsibility for the technical implementation of each clinical trial including software development of PHT's LogPadTM, SitePadTM, Data Delivery, and Study Archive. Mr. Cooper joined PHT in 2001 as Director of Engineering. Previously he co-founded Beehive Software, and spent five years providing software consulting services for pharmaceutical manufacturers including Eli Lilly. Mr. Cooper has a B.S. in Electrical Engineering and an M.S. in Computer Science from Union College in Schenectady, New York.

PHT President and CEO Phil Lee said, "Dwight Cooper's commitment to quality and timely delivery have earned him an excellent reputation among our customers and throughout the pharmaceutical industry. Dwight has contributed significantly to PHT's success in delivering world-class Client Services and establishing our leadership in the ePRO market. His ability to understand and anticipate customer needs and his in-depth technology knowledge make him the ideal person for this important position."

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorksTM features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPROTM email alerts, and the industry's premier study archive. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least 12 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.

Suggested Articles

In a pandemic world, the biotech funding environment couldn’t look brighter, and today Pfizer shone its own light.

Gilead is tapping long-term Stanford University researcher Mark Genovese, M.D., to lead its NASH, fibrosis and arthritis pipeline programs.

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…